Canadian Network on Hepatitis C (CanHepC) – Rapid Funding for DSEN Cont’d III
NPI: Sasha Bernatsky Co-PI: Marina Klein, Jordan Feld, and Louise Pilote Duration: 1 year We have been funded to answer a query related to the
Pharmacoepidemiology in Multiple Sclerosis (PiMS) Research Group – Rapid Funding for DSEN Cont’d II
NPI: Sasha Bernatsky Co-PI: Helen Tremlett and Louise Pilote Duration: 1 year We have been funded to enhance the clinical cohort in multiple sclerosis (MS)
Progress with innovations to CATCH EDC – Rapid Funding for DSEN Cont’d
This project aims to build capacity for drug safety and effectiveness research in rheumatoid arthritis (RA) in Canada. Funding has allowed enhancement of a very
Rapid Funding for DSEN Targeted Research
Drs. Sasha Bernatsky and Louise Pilote received funding from the Drug Safety and Effectiveness Network (DSEN) Rapid Funding for DSEN Targeted Research to continue developing
Post-market drug safety and effectiveness in ankylosing spondylitis (AS)
Query 10-22b: The effects of Disease-Modifying Anti-Rheumatic Drugs (DMARDs) in Ankylosing Spondylitis (AS). This research was funded by the Drug Safety and Effectiveness Network (DSEN)
Newer antidepressants and pediatric pulmonary hypertension
Query 12-10: Newer antidepressants and Persistent Pulmonary Hypertension of the Newborn (PPHN). This research was funded by the Drug Safety and Effectiveness Network (DSEN) and